An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia
2016 · Leukemia & lymphoma/Leukemia and lymphoma · 74 citations
https://doi.org/10.3109/10428194.2015.1122781
X
Xuejing Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
158
Papers
2.1K
Citations
23
h-index
45
i10-index
Xuejing Wang is an academic researcher from Wannan Medical College. The author has contributed to research in topics: Genetic diversity and population structure & Chronic Kidney Disease and Diabetes & MicroRNA in disease regulation. The author has an h-index of 23, co-authored 135 publications.
ORCID: 0000-0002-1258-8214Papers by this author
worksApplication of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial
2012 · Journal of Translational Medicine · 50 citations
https://doi.org/10.1186/1479-5876-10-s1-s14
Genetic, phenotypic and ecological differentiation suggests incipient speciation in two Charadrius plovers along the Chinese coast
2019 · BMC Evolutionary Biology · 39 citations
https://doi.org/10.1186/s12862-019-1449-5
Autophagy is involved in the replication of H9N2 influenza virus via the regulation of oxidative stress in alveolar epithelial cells
2021 · Virology Journal · 34 citations
https://doi.org/10.1186/s12985-020-01484-x
Cyclosporine A protects podocytes via stabilization of cofilin-1 expression in the unphosphorylated state
2014 · Experimental Biology and Medicine · 32 citations
https://doi.org/10.1177/1535370214530365
A non-randomized, open-label, single-arm, Phase 2 study of emibetuzumab in Asian patients with MET diagnostic positive, advanced gastric cancer
2017 · Cancer Chemotherapy and Pharmacology · 30 citations
https://doi.org/10.1007/s00280-017-3445-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat